ABSTRACT
The lack of socioeconomic status (SES) data in state cancer registries has been recognized for years. On the one hand, lack of income measures is an important drawback for cancer registry data. Linking cancer screening program participants, who were all relatively low income and underinsured, provided an indirect way of measuring income effects. On the other hand, breast cancer screening programs funded by the Centers for Disease Control and Prevention have been implemented for more than 20 years, but few studies have evaluated their mortality outcomes. The chapter aims to evaluate treatment and mortality under the premise that the same stage of cancer diagnosis should have the same treatment, and the same treatment should lead to similar mortality outcomes. Compared to all non-Every Woman Matters (EWM) participants, women diagnosed through EWM were more likely to survive within 3 years of diagnosis.
